Form 4: Director Robert F. Friel Receives WST Stock Grant

West Pharmaceutical Services Director Robert F. Friel acquired 791 shares of common stock via a restricted stock unit grant.

Summary

• Director Robert F. Friel was granted 791 restricted stock units (RSUs) on May 4, 2026.
• The shares were acquired at a price of $0 as part of director compensation.
• Following this transaction, the director's total beneficial ownership in West Pharmaceutical Services stands at 5,512.97 shares.
• The RSUs are scheduled to vest in full on the date of the next annual shareholder meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial strategy.

Positives

• The transaction reflects ongoing alignment between the director and shareholder interests through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market fluctuations in West Pharmaceutical Services stock price.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting and are subject to the company's Deferred Compensation Plan for Outside Directors.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a vested interest in the long-term performance of the company.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for S&P 500 and mid-cap healthcare companies.
• The vesting schedule tied to the annual shareholder meeting is a common retention mechanism for board members.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity-based compensation event.

Next Steps

• Vesting of the 791 restricted stock units at the next annual shareholder meeting.

Key Dates

Keywords

West Pharmaceutical Services, WST, Form 4, Insider Trading, Director Compensation, Equity Grant